Angiotech Pharmaceuticals, Inc. Loss Widens As Royalties Slow

TORONTO July 30 (Reuters) - Angiotech Pharmaceuticals Inc (ANP.TO) said its second-quarter loss widened on Friday as royalty payments from its marketing partners slowed.

MORE ON THIS TOPIC